+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Microbiome - Market Analysis, Trends, and Forecasts

  • ID: 4805537
  • Report
  • October 2019
  • Region: Global
  • 146 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Dowdupont
  • Enterome Sa
  • Merck & Co.
  • Metabiomics Corporation
  • Microbiome Therapeutics
  • Osel, Inc.
  • MORE
The Human Microbiome market worldwide is projected to grow by US$542.3 Million, driven by a compounded growth of 14.6%. Acute Diarrhea, one of the segments analyzed and sized in this study, displays the potential to grow at over 15.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$476.7 Million by the year 2025, Acute Diarrhea will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 15.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$20.9 Million to the region's size and clout in the next 5 to 6 years. Over US$26 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Acute Diarrhea will reach a market size of US$36.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 14.3% over the next couple of years and add approximately US$94.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • DowDuPont, Inc.
  • Enterome SA
  • Merck & Co., Inc.
  • Metabiomics Corporation
  • Microbiome Therapeutics, LLC.
  • Osel, Inc.
  • Second Genome
  • Vedanta Biosciences, Inc.
  • ViThera Pharmaceuticals, Inc.
  • Yakult Honsha Co., Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Dowdupont
  • Enterome Sa
  • Merck & Co.
  • Metabiomics Corporation
  • Microbiome Therapeutics
  • Osel, Inc.
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Human Microbiome Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Human Microbiome Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Human Microbiome Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

TABLE 3: Therapeutics (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025

TABLE 4: Therapeutics (Application) Market Share Shift across Key Geographies: 2019 VS 2025

TABLE 5: Diagnostics (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 6: Diagnostics (Application) Market Share Breakdown by Region/Country: 2019 VS 2025

TABLE 7: Probiotics (Product Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 8: Probiotics (Product Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

TABLE 9: Prebiotics (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 10: Prebiotics (Product Type) Market Share Breakdown by Region/Country: 2019 VS 2025

TABLE 11: Foods (Product Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 12: Foods (Product Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

TABLE 13: Medical Foods (Product Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025

TABLE 14: Medical Foods (Product Type) Market Percentage Share Distribution by Region/Country: 2019 VS 2025

TABLE 15: Drugs (Product Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025

TABLE 16: Drugs (Product Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

TABLE 17: Other Product Types (Product Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 18: Other Product Types (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

TABLE 19: Acute Diarrhea (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 20: Acute Diarrhea (Disease Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

TABLE 21: Obesity (Disease Indication) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 22: Obesity (Disease Indication) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025

TABLE 23: Diabetes (Disease Indication) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 24: Diabetes (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

TABLE 25: Autoimmune Disorders (Disease Indication) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 26: Autoimmune Disorders (Disease Indication) Market Share Breakdown by Region/Country: 2019 VS 2025

TABLE 27: Cancer (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 28: Cancer (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

TABLE 29: Mental Disorders (Disease Indication) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025

TABLE 30: Mental Disorders (Disease Indication) Market Percentage Share Distribution by Region/Country: 2019 VS 2025

TABLE 31: Other Diseases (Disease Indication) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025

TABLE 32: Other Diseases (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Human Microbiome Market Share (in %) by Company: 2019 & 2025

TABLE 33: United States Human Microbiome Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025

TABLE 34: Human Microbiome Market Share Breakdown in the United States by Application: 2019 VS 2025

TABLE 35: United States Human Microbiome Market Estimates and Projections in US$ Thousand by Product Type: 2018 to 2025

TABLE 36: United States Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025

TABLE 37: United States Human Microbiome Market Estimates and Projections in US$ Thousand by Disease Indication: 2018 to 2025

TABLE 38: United States Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025

CANADA

TABLE 39: Canadian Human Microbiome Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025

TABLE 40: Canadian Human Microbiome Market Share Analysis by Application: 2019 VS 2025

TABLE 41: Canadian Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018 to 2025

TABLE 42: Human Microbiome Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2019 and 2025

TABLE 43: Canadian Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025

TABLE 44: Human Microbiome Market in Canada: Percentage Share Breakdown of Sales by Disease Indication for 2019 and 2025

JAPAN

TABLE 45: Japanese Demand Estimates and Forecasts for Human Microbiome in US$ Thousand by Application: 2018 to 2025

TABLE 46: Human Microbiome Market Share Shift in Japan by Application: 2019 VS 2025

TABLE 47: Japanese Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Product Type for the Period 2018-2025

TABLE 48: Japanese Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025

TABLE 49: Japanese Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 50: Japanese Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025

CHINA

TABLE 51: Chinese Demand for Human Microbiome in US$ Thousand by Application: 2018 to 2025

TABLE 52: Chinese Human Microbiome Market Share Breakdown by Application: 2019 VS 2025

TABLE 53: Chinese Human Microbiome Market Growth Prospects in US$ Thousand by Product Type for the Period 2018-2025

TABLE 54: Chinese Human Microbiome Market by Product Type: Percentage Breakdown of Sales for 2019 and 2025

TABLE 55: Chinese Human Microbiome Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 56: Chinese Human Microbiome Market by Disease Indication: Percentage Breakdown of Sales for 2019 and 2025

EUROPE

Market Facts & Figures

European Human Microbiome Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 57: European Human Microbiome Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 58: European Human Microbiome Market Share Shift by Region/Country: 2019 VS 2025

TABLE 59: European Human Microbiome Addressable Market Opportunity in US$ Thousand by Application: 2018-2025

TABLE 60: European Human Microbiome Market Share Analysis by Application: 2019 VS 2025

TABLE 61: European Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018-2025

TABLE 62: European Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025

TABLE 63: European Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025

TABLE 64: European Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025

FRANCE

TABLE 65: Human Microbiome Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025

TABLE 66: French Human Microbiome Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025

TABLE 67: Human Microbiome Market in France by Product Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 68: French Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025

TABLE 69: Human Microbiome Market in France by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 70: French Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025

GERMANY

TABLE 71: Human Microbiome Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025

TABLE 72: Human Microbiome Market Share Distribution in Germany by Application: 2019 VS 2025

TABLE 73: Human Microbiome Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product Type for the Period 2018-2025

TABLE 74: German Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025

TABLE 75: Human Microbiome Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 76: German Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025

ITALY

TABLE 77: Italian Demand for Human Microbiome in US$ Thousand by Application: 2018 to 2025

TABLE 78: Italian Human Microbiome Market Share Breakdown by Application: 2019 VS 2025

TABLE 79: Italian Human Microbiome Market Growth Prospects in US$ Thousand by Product Type for the Period 2018-2025

TABLE 80: Italian Human Microbiome Market by Product Type: Percentage Breakdown of Sales for 2019 and 2025

TABLE 81: Italian Human Microbiome Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 82: Italian Human Microbiome Market by Disease Indication: Percentage Breakdown of Sales for 2019 and 2025

UNITED KINGDOM

TABLE 83: United Kingdom Demand Estimates and Forecasts for Human Microbiome in US$ Thousand by Application: 2018 to 2025

TABLE 84: Human Microbiome Market Share Shift in the United Kingdom by Application: 2019 VS 2025

TABLE 85: United Kingdom Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Product Type for the Period 2018-2025

TABLE 86: United Kingdom Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025

TABLE 87: United Kingdom Market for Human Microbiome: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 88: United Kingdom Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025

REST OF EUROPE

TABLE 89: Rest of Europe Human Microbiome Addressable Market Opportunity in US$ Thousand by Application: 2018-2025

TABLE 90: Rest of Europe Human Microbiome Market Share Analysis by Application: 2019 VS 2025

TABLE 91: Rest of Europe Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018-2025

TABLE 92: Rest of Europe Human Microbiome Market Share Breakdown by Product Type: 2019 VS 2025

TABLE 93: Rest of Europe Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025

TABLE 94: Rest of Europe Human Microbiome Market Share Breakdown by Disease Indication: 2019 VS 2025

ASIA-PACIFIC

TABLE 95: Human Microbiome Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025

TABLE 96: Asia-Pacific Human Microbiome Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025

TABLE 97: Human Microbiome Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 98: Asia-Pacific Human Microbiome Market Share Analysis by Product Type: 2019 VS 2025

TABLE 99: Human Microbiome Market in Asia-Pacific by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 100: Asia-Pacific Human Microbiome Market Share Analysis by Disease Indication: 2019 VS 2025

REST OF WORLD

TABLE 101: Rest of World Human Microbiome Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025

TABLE 102: Rest of World Human Microbiome Market Share Analysis by Application: 2019 VS 2025

TABLE 103: Rest of World Human Microbiome Market Estimates and Forecasts in US$ Thousand by Product Type: 2018 to 2025

TABLE 104: Human Microbiome Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2019 and 2025

TABLE 105: Rest of World Human Microbiome Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025

TABLE 106: Human Microbiome Market in Rest of World: Percentage Share Breakdown of Sales by Disease Indication for 2019 and 2025

IV. COMPETITION

DOWDUPONT

ENTEROME SA

MERCK & CO.

METABIOMICS CORPORATION

MICROBIOME THERAPEUTICS

OSEL, INC.

SECOND GENOME

VEDANTA BIOSCIENCES, INC.

VITHERA PHARMACEUTICALS

YAKULT HONSHA

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Dowdupont
  • Enterome Sa
  • Merck & Co.
  • Metabiomics Corporation
  • Microbiome Therapeutics
  • Osel, Inc.
  • Second Genome
  • Vedanta Biosciences, Inc.
  • Vithera Pharmaceuticals
  • Yakult Honsha
Note: Product cover images may vary from those shown
Adroll
adroll